Edwards Lifesciences Weighted Average Share Growth Trend

EW -- USA Stock  

USD 153.60  1.42  0.93%

This module enables investors to look at Edwards Lifesciences various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 560.2 M, Cost of Revenue of 744.5 M or Earning Before Interest and Taxes EBIT of 735.1 M, but also many exotic indicators such as Interest Coverage of 83.0439, Long Term Debt to Equity of 0.2914 or Calculated Tax Rate of 22.793. This module is a perfect complement to use when analyzing Edwards Lifesciences Valuation or Volatility. It can also complement various Edwards Lifesciences Technical models. Additionally see analysis of Edwards Lifesciences Correlation with competitors.
Showing smoothed Weighted Average Share Growth of Edwards Lifesciences Corporation with missing and latest data points interpolated. Measures the growth in Weighted Average Shares over the specified period.
Weighted Average Share Growth10 Years Trend
 Weighted Average Share Growth 

Regression Statistics

Arithmetic Mean (0.003163)
Geometric Mean  0.011279
Coefficient Of Variation (630.43)
Mean Deviation  0.016684
Median  0.007916
Standard Deviation  0.019939
Sample Variance  0.00039758
Range  0.06
R Value  0.26
Mean Square Error  0.00040361
R Squared  0.07
Significance  0.38
Slope  0.001349
Total Sum of Squares  0.004771

Edwards Lifesciences Weighted Average Share Growth Over Time

2016-12-31  0.011737 
2017-12-31  0.011737 
2018-12-31  0.013808 

Other Fundumenentals

Thematic Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Thematic Ideas
Explore Investing Ideas  

Upcoming Events

Edwards Lifesciences Upcoming Company Events
Upcoming Quarterly ReportApril 25, 2017
Next Earnings ReportJuly 25, 2017
Additionally see analysis of Edwards Lifesciences Correlation with competitors. Please also try Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.